These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 32894281)

  • 1. Long non-coding RNA PSMA3-AS1 enhances cell proliferation, migration and invasion by regulating miR-302a-3p/RAB22A in glioma.
    Zhou LL; Zhang M; Zhang YZ; Sun MF
    Biosci Rep; 2020 Sep; 40(9):. PubMed ID: 32894281
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long non-coding RNA PSMA3-AS1 promotes glioma progression through modulating the miR-411-3p/HOXA10 pathway.
    Huang T; Chen Y; Zeng Y; Xu C; Huang J; Hu W; Chen X; Fu H
    BMC Cancer; 2021 Jul; 21(1):844. PubMed ID: 34294084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MSC-AS1 knockdown inhibits cell growth and temozolomide resistance by regulating miR-373-3p/CPEB4 axis in glioma through PI3K/Akt pathway.
    Li C; Feng S; Chen L
    Mol Cell Biochem; 2021 Feb; 476(2):699-713. PubMed ID: 33106913
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long noncoding RNA PSMA3-AS1 functions as a competing endogenous RNA to promote gastric cancer progression by regulating the miR-329-3p/ALDOA axis.
    Kan L; Yang M; Zhang H
    Biol Direct; 2023 Jul; 18(1):36. PubMed ID: 37403106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LncRNA PSMA3-AS1 promotes preterm delivery by inducing ferroptosis via miR-224-3p/Nrf2 axis.
    Qiu L; Lin X; Chen R; Wu Y; Yan J
    Cell Mol Biol (Noisy-le-grand); 2023 Dec; 69(13):270-278. PubMed ID: 38158666
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Silencing lncRNA-DARS-AS1 suppresses nonsmall cell lung cancer progression by stimulating miR-302a-3p to inhibit ACAT1 expression.
    Li J; Li Y; Sun X; Wei L; Guan J; Fu L; Du J; Zhang X; Cheng M; Ma H; Jiang S; Zheng Q; Wang L
    Mol Carcinog; 2024 Apr; 63(4):757-771. PubMed ID: 38289172
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long noncoding RNA DLGAP1-AS1 promotes the progression of glioma by regulating the miR-1297/EZH2 axis.
    Liu L; Li X; Shi Y; Chen H
    Aging (Albany NY); 2021 Apr; 13(8):12129-12142. PubMed ID: 33901010
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LncRNA PSMA3-AS1 promotes cell proliferation, migration, and invasion in ovarian cancer by activating the PI3K/Akt pathway via the miR-378a-3p/GALNT3 axis.
    Xu Z; Jin H; Duan X; Liu H; Zhao X; Fan S; Wang Y; Yao T
    Environ Toxicol; 2021 Dec; 36(12):2562-2577. PubMed ID: 34520102
    [TBL] [Abstract][Full Text] [Related]  

  • 9. PSMA3-AS1 induced by transcription factor PAX5 promotes cholangiocarcinoma proliferation, migration and invasion by sponging miR-376a-3p to up-regulate LAMC1.
    Sun D; Li F; Liu L; Yu S; Wang H; Gao X; Liu G; Zhao Y; Qiu G; Jiang X
    Aging (Albany NY); 2022 Jan; 14(1):509-525. PubMed ID: 35022330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SUMOylation of IGF2BP2 promotes vasculogenic mimicry of glioma via regulating OIP5-AS1/miR-495-3p axis.
    Li H; Wang D; Yi B; Cai H; Wang Y; Lou X; Xi Z; Li Z
    Int J Biol Sci; 2021; 17(11):2912-2930. PubMed ID: 34345216
    [No Abstract]   [Full Text] [Related]  

  • 11. Long Non-coding RNA COX10-AS1 Promotes Glioma Progression by Competitively Binding miR-1-3p to Regulate ORC6 Expression.
    Zhang G; Tao X; Ji BW; Gong J
    Neuroscience; 2024 Mar; 540():68-76. PubMed ID: 38244670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long non-coding RNA SOX21-AS1 promotes cell proliferation and invasion through upregulating PAK7 expression by sponging miR-144-3p in glioma cells.
    Gai SY; Yuan ZH
    Neoplasma; 2020 Mar; 67(2):333-343. PubMed ID: 31973536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long non-coding RNA TP73-AS1 sponges miR-194 to promote colorectal cancer cell proliferation, migration and invasion via up-regulating TGFα.
    Cai Y; Yan P; Zhang G; Yang W; Wang H; Cheng X
    Cancer Biomark; 2018; 23(1):145-156. PubMed ID: 30010111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LncRNA PSMA3-AS1 promotes colorectal cancer cell migration and invasion via regulating miR-4429.
    Peng P; Wang Y; Wang BL; Song YH; Fang Y; Ji H; Huangfu CN; Wang KM; Zheng Q
    Eur Rev Med Pharmacol Sci; 2020 Nov; 24(22):11594-11601. PubMed ID: 33275226
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA GAS5-AS1 inhibits glioma proliferation, migration, and invasion via miR-106b-5p/TUSC2 axis.
    Huang W; Shi Y; Han B; Wang Q; Zhang B; Qi C; Liu F
    Hum Cell; 2020 Apr; 33(2):416-426. PubMed ID: 32072565
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long Noncoding RNA HOXD-AS1 Promotes the Proliferation, Migration, and Invasion of Colorectal Cancer via the miR-526b-3p/CCND1 Axis.
    Yan F; Ma Y; Liu L; Li L; Deng J; Sun J
    J Surg Res; 2020 Nov; 255():525-535. PubMed ID: 32640404
    [TBL] [Abstract][Full Text] [Related]  

  • 17. LncRNA NNT-AS1 promote glioma cell proliferation and metastases through miR-494-3p/PRMT1 axis.
    Zheng D; Chen D; Lin F; Wang X; Lu L; Luo S; Chen J; Xu X
    Cell Cycle; 2020 Jul; 19(13):1621-1631. PubMed ID: 32420808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LncRNA MSC-AS1 motivates the development of melanoma by binding to miR-302a-3p and recruiting IGF2BP2 to elevate LEF1 expression.
    Ma Y; Jin Y; Li C; Liu Y; Wang D
    Exp Dermatol; 2021 Dec; 30(12):1764-1774. PubMed ID: 34218464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. LncRNA LOXL1-AS1 inhibited cell proliferation, migration and invasion as well as induced apoptosis in breast cancer via regulating miR-143-3p.
    Li GH; Yu JH; Yang B; Gong FC; Zhang KW
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10400-10409. PubMed ID: 31841194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The knockdown of LncRNA AFAP1-AS1 suppressed cell proliferation, migration, and invasion, and promoted apoptosis by regulating miR-545-3p/hepatoma-derived growth factor axis in lung cancer.
    Sun J; Min H; Yu L; Yu G; Shi Y; Sun J
    Anticancer Drugs; 2021 Jan; 32(1):11-21. PubMed ID: 33290312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.